EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Using Polygenic Risk Scores to Aid Diagnosis of Patients With Early Inflammatory Arthritis: Results From the Norfolk Arthritis Register

Ryan M Hum iD, Seema D Sharma iD, Michael Stadler iD, Sebastien Viatte iD, Pauline Ho iD, Nisha Nair iD, Chenfu Shi iD, Chuan Fu Yap iD, Mehreen Soomro iD, Darren Plant iD, Jenny H Humphreys iD, Alexander MacGregor iD und 5 weitere

Arthritis & Rheumatology · 2024

DOI: 10.1002/art.42760 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Arthritis & Rheumatology, 2024. Verfasst von Ryan M Hum und 16 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Musculoskeletal Research, NIHR Manchester Biomedical Research Centre, Lydia Becker Institute of Immunology and Inflammation, The Universit…. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Arthritis, Rheumatoid, Registries. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Versus Arthritis, Arthritis Research UK, Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

There is growing evidence that genetic data are of benefit in the rheumatology outpatient setting by aiding early diagnosis. A genetic probability tool (G‐PROB) has been developed to aid diagnosis has not yet been tested in a real‐world setting. Our aim was to assess whether G‐PROB could aid diagnosis in the rheumatology outpatient setting using data from the Norfolk Arthritis Register (NOAR), a prospective observational cohort of patients presenting with early inflammatory arthritis.

Methods

Genotypes and clinician diagnoses were obtained from patients from NOAR. Six G‐probabilities (0%–100%) were created for each patient based on known disease‐associated odds ratios of published genetic risk variants, each corresponding to one disease of rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, spondyloarthropathy, gout, or “other diseases.” Performance of the G‐probabilities compared with clinician diagnosis was assessed.

Results

We tested G‐PROB on 1,047 patients. Calibration of G‐probabilities with clinician diagnosis was high, with regression coefficients of 1.047, where 1.00 is ideal. G‐probabilities discriminated clinician diagnosis with pooled areas under the curve (95% confidence interval) of 0.85 (0.84–0.86). G‐probabilities 2 unlikely diseases for 94% of patients and >3 for 53.7% of patients. G‐probabilities >50% corresponded to a positive predictive value of 70.4%. In 55.7% of patients, the disease with the highest G‐probability corresponded to clinician diagnosis.

Conclusion

G‐PROB converts complex genetic information into meaningful and interpretable conditional probabilities, which may be especially helpful at eliminating unlikely diagnoses in the rheumatology outpatient setting. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, PsoriaticArthritis, RheumatoidRegistriesAdultAgedFemaleHumansMaleMiddle AgedArthritisEarly DiagnosisGenetic Predisposition to DiseaseGenetic Risk ScoreLupus Erythematosus, SystemicProspective StudiesRisk AssessmentSpondylarthropathies

Autor:innen und Institutionen

  • Centre for Musculoskeletal Research, NIHR Manchester Biomedical Research Centre, Lydia Becker Institute of Immunology and Inflammation, The University of Manchester, Manchester, UK.
  • Norwich Medical School, University of East Anglia, Norwich, UK.

ORCID-Profile: Ryan M Hum, Seema D Sharma, Michael Stadler, Sebastien Viatte, Pauline Ho, Nisha Nair, Chenfu Shi, Chuan Fu Yap, Mehreen Soomro, Darren Plant, Jenny H Humphreys, Alexander MacGregor, Max Yates, Suzanne Verstappen, Anne Barton, John Bowes

Förderung

  • Versus Arthritis
  • Arthritis Research UK
  • Swiss National Science Foundation
  • Innovative Medicines Initiative
  • National Institute for Health and Care Research

Zitieren

APA

Hum, R. M., Sharma, S. D., Stadler, M., Viatte, S., Ho, P., Nair, N., Shi, C., Yap, C. F., Soomro, M., Plant, D., Humphreys, J. H., MacGregor, A., Yates, M., Verstappen, S., Barton, A., Bowes, J., & all NOAR collaborators (2024). Using Polygenic Risk Scores to Aid Diagnosis of Patients With Early Inflammatory Arthritis: Results From the Norfolk Arthritis Register. Arthritis & Rheumatology. https://doi.org/10.1002/art.42760

Vancouver

Hum RM, Sharma SD, Stadler M, Viatte S, Ho P, Nair N, et al. Using Polygenic Risk Scores to Aid Diagnosis of Patients With Early Inflammatory Arthritis: Results From the Norfolk Arthritis Register. Arthritis & Rheumatology. 2024. doi:10.1002/art.42760

BibTeX
@article{Hum2024,
  author = {Hum, Ryan M and Sharma, Seema D and Stadler, Michael and Viatte, Sebastien and Ho, Pauline and Nair, Nisha and Shi, Chenfu and Yap, Chuan Fu and Soomro, Mehreen and Plant, Darren and Humphreys, Jenny H and MacGregor, Alexander and Yates, Max and Verstappen, Suzanne and Barton, Anne and Bowes, John and all NOAR collaborators, all NOAR collaborators},
  title = {Using Polygenic Risk Scores to Aid Diagnosis of Patients With Early Inflammatory Arthritis: Results From the Norfolk Arthritis Register},
  journal = {Arthritis & Rheumatology},
  year = {2024},
  doi = {10.1002/art.42760}
}
Kostenlos starten →